IFP Advisors’s Fate Therapeutics FATE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$96 Buy
+85
New +$96 ﹤0.01% 4738
2025
Q1
Sell
-28
Closed -$46 4438
2024
Q4
$46 Buy
+28
New +$46 ﹤0.01% 4280
2024
Q3
Sell
-3,360
Closed -$11K 3351
2024
Q2
$11K Hold
3,360
﹤0.01% 2309
2024
Q1
$24.7K Hold
3,360
﹤0.01% 1879
2023
Q4
$12.6K Hold
3,360
﹤0.01% 2104
2023
Q3
$7.12K Hold
3,360
﹤0.01% 2393
2023
Q2
$16K Hold
3,360
﹤0.01% 2119
2023
Q1
$36.7K Sell
3,360
-553
-14% -$6.03K ﹤0.01% 1735
2022
Q4
$44K Buy
3,913
+37
+1% +$416 ﹤0.01% 2329
2022
Q3
$43K Buy
3,876
+34
+0.9% +$377 ﹤0.01% 2484
2022
Q2
$43K Hold
3,842
﹤0.01% 2267
2022
Q1
$43K Buy
+3,842
New +$43K ﹤0.01% 2267
2021
Q3
Hold
0
3738
2021
Q2
Sell
-150
Closed -$12K 3476
2021
Q1
$12K Buy
+150
New +$12K ﹤0.01% 2044
2020
Q4
Hold
0
3284
2020
Q3
Hold
0
3156
2020
Q2
Hold
0
3033
2020
Q1
Hold
0
3022
2019
Q4
Sell
-20
Closed 3082
2019
Q3
$0 Buy
+20
New ﹤0.01% 3247
2019
Q1
Sell
-24,158
Closed -$292K 2668
2018
Q4
$292K Buy
24,158
+3,184
+15% +$38.5K 0.02% 723
2018
Q3
$342K Sell
20,974
-3,526
-14% -$57.5K 0.01% 824
2018
Q2
$278K Buy
24,500
+14,900
+155% +$169K 0.01% 905
2018
Q1
$59K Hold
9,600
﹤0.01% 1718
2017
Q4
$59K Buy
9,600
+4,000
+71% +$24.6K ﹤0.01% 1715
2017
Q3
$22K Buy
5,600
+500
+10% +$1.96K ﹤0.01% 2506
2017
Q2
$17K Sell
5,100
-300
-6% -$1K ﹤0.01% 2641
2017
Q1
$25K Sell
5,400
-6,640
-55% -$30.7K ﹤0.01% 2330
2016
Q4
$30K Buy
12,040
+5,840
+94% +$14.6K ﹤0.01% 2181
2016
Q3
$19K Buy
6,200
+1,000
+19% +$3.07K ﹤0.01% 2412
2016
Q2
$9K Buy
+5,200
New +$9K ﹤0.01% 2780
2016
Q1
Sell
-5,200
Closed -$18K 2697
2015
Q4
$18K Buy
+5,200
New +$18K ﹤0.01% 2204